These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 785434)

  • 21. Preliminary experience with rifampicin and isoprodian (L73A)--combination in lepromatous leprosy.
    Hamzah M; Kosasih A
    Lepr Rev; 1975 Jun; 46(2 Suppl):181-7. PubMed ID: 1100959
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure of a prothionamide-containing oral antituberculosis regimen.
    Langton ME; Cowie RL
    S Afr Med J; 1985 Dec; 68(12):881. PubMed ID: 4071346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary experience with combined therapy using rifampicin and isoprodian (L73A).
    Freerksen E
    Lepr Rev; 1975 Jun; 46(2 Suppl):161-3. PubMed ID: 1165695
    [No Abstract]   [Full Text] [Related]  

  • 24. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
    Krenzien HN
    Lepr Rev; 1975 Jun; 46(2 Suppl):189-98. PubMed ID: 1100960
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of open cavernous pulmonary tuberculosis (author's transl)].
    Kittel H
    Dtsch Med Wochenschr; 1979 Mar; 104(13):477-9. PubMed ID: 436602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.
    Aschhoff M
    Lepr Rev; 1975 Jun; 46(2 Suppl):173-8. PubMed ID: 1165697
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
    Innami S; Leguizamón OR; Alvarenga AE
    Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
    [No Abstract]   [Full Text] [Related]  

  • 28. [New drugs in the treatment of leprosy].
    De Las Aguas JT
    Med Cutan Ibero Lat Am; 1976; 4(5):365-70. PubMed ID: 1035391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary tuberculosis treated with isoprodian and rifampicin or pyrazinamide.
    Kleeberg HH
    Chemotherapy; 1987; 33(3):219-28. PubMed ID: 3297528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of low dosage prothionamide with and without 4,4'-diamino diphenyl sulphone for use with isoniazid in the treatment of experimental mouse tuberculosis.
    Grosset J; Truffot C; Boval C
    Tubercle; 1982 Mar; 63(1):37-43. PubMed ID: 7080212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Haemoglobin levels during prolonged treatment with isoprodian, a combination of isoniazid, prothionamide and diaphenylsulphone (author's transl)].
    Hoose C
    Prax Pneumol; 1976 Jul; 30(7):435-8. PubMed ID: 967821
    [No Abstract]   [Full Text] [Related]  

  • 33. [Advances in anti-tuberculosis therapy (author's transl)].
    Freeksen E; Rosenfeld M
    Prax Pneumol; 1976 Aug; 30(8):489-502. PubMed ID: 959157
    [No Abstract]   [Full Text] [Related]  

  • 34. Isoprodian and rifampicin in the treatment of leprosy: a descriptive evaluation of therapy durations in 475 Paraguayan leprosy patients.
    Pritze S; Alvarenga AE; Leguizamon O; Haubitz I
    Chemotherapy; 1989; 35(5):373-82. PubMed ID: 2676405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of therapeutic efficacy and toxicity of ethionamide and prothionamide in Indian patients.
    Gupta DK; Mital OP; Agarwal MC; Kansal HM; Nath S
    J Indian Med Assoc; 1977 Jan; 68(2):25-9. PubMed ID: 326974
    [No Abstract]   [Full Text] [Related]  

  • 36. The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
    Depasquale G
    Lepr Rev; 1986; 57 Suppl 3():29-37. PubMed ID: 3573957
    [No Abstract]   [Full Text] [Related]  

  • 37. New forms of multidrug therapy for the treatment of leprosy. First report for the practice on rifampicin + sulfamethoxazole-trimethoprim + protionamide and rifampicin + sulfamethoxazole-trimethoprim + isoniazid.
    Freerksen E; Rosenfeld M; Spannuth G
    Chemotherapy; 1989; 35(2):133-9. PubMed ID: 2758869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness of treatment with rifampicin and isoniazid in association with ethambutol or prothionamide in patients with recently detected pulmonary tuberculosis].
    Homenko AG; Ciukanov VL
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(4):211-8. PubMed ID: 232302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bacteriostatic activity of blood in single and combined use of ethionamide or prothionamide].
    Kozulitsyna TI; Korotaev GA
    Probl Tuberk; 1975; (5):70-3. PubMed ID: 1144350
    [No Abstract]   [Full Text] [Related]  

  • 40. On the mechanism of the antimycobacterial activity of isoniazid + prothionamide + dapsone (Isoprodian).
    Urbanczik R
    Chemotherapy; 1979; 25(5):261-7. PubMed ID: 477453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.